全文获取类型
收费全文 | 4831篇 |
免费 | 426篇 |
国内免费 | 34篇 |
专业分类
耳鼻咽喉 | 21篇 |
儿科学 | 215篇 |
妇产科学 | 72篇 |
基础医学 | 685篇 |
口腔科学 | 121篇 |
临床医学 | 554篇 |
内科学 | 996篇 |
皮肤病学 | 89篇 |
神经病学 | 275篇 |
特种医学 | 337篇 |
外科学 | 916篇 |
综合类 | 56篇 |
一般理论 | 2篇 |
预防医学 | 314篇 |
眼科学 | 83篇 |
药学 | 317篇 |
中国医学 | 5篇 |
肿瘤学 | 233篇 |
出版年
2023年 | 35篇 |
2022年 | 36篇 |
2021年 | 65篇 |
2020年 | 60篇 |
2019年 | 74篇 |
2018年 | 109篇 |
2017年 | 104篇 |
2016年 | 97篇 |
2015年 | 126篇 |
2014年 | 140篇 |
2013年 | 229篇 |
2012年 | 200篇 |
2011年 | 185篇 |
2010年 | 154篇 |
2009年 | 155篇 |
2008年 | 170篇 |
2007年 | 196篇 |
2006年 | 205篇 |
2005年 | 155篇 |
2004年 | 145篇 |
2003年 | 128篇 |
2002年 | 149篇 |
2001年 | 133篇 |
2000年 | 132篇 |
1999年 | 144篇 |
1998年 | 143篇 |
1997年 | 137篇 |
1996年 | 133篇 |
1995年 | 104篇 |
1994年 | 97篇 |
1993年 | 68篇 |
1992年 | 79篇 |
1991年 | 96篇 |
1990年 | 87篇 |
1989年 | 73篇 |
1988年 | 93篇 |
1987年 | 94篇 |
1986年 | 85篇 |
1985年 | 84篇 |
1984年 | 64篇 |
1983年 | 59篇 |
1982年 | 50篇 |
1981年 | 46篇 |
1980年 | 39篇 |
1979年 | 49篇 |
1978年 | 33篇 |
1977年 | 35篇 |
1976年 | 29篇 |
1975年 | 28篇 |
1970年 | 22篇 |
排序方式: 共有5291条查询结果,搜索用时 46 毫秒
1.
2.
3.
P Avalos-Peralta† A Herrera† JJ Ríos-Martín‡ AM Pérez-Bernal† D Moreno-Ramírez† F Camacho† 《Journal of the European Academy of Dermatology and Venereology》2006,20(1):79-83
We report the case of a patient with a 13-year history of pemphigus vulgaris (PV) treated with immunosuppressive agents, prednisone and mycophenolate mofetil who had developed lesions of Kaposi's sarcoma (KS) on a sole plaque of PV that had been previously treated with intralesional injections of steroids. The lesions were surgically removed and polymerase chain reaction (PCR) demonstrated human herpesvirus-8 (HHV-8) DNA. There were neither recurrences nor later dissemination of KS following gradual decrease of the immunosuppressive therapy. We suggest that the treatment with intralesional steroids may have influenced the local reactivation of a latent infection of the virus, determining the appearance of this localized KS. 相似文献
4.
5.
Relation between energy expenditure and body composition in man: specific energy expenditure in vivo of fat and fat-free tissue 总被引:2,自引:0,他引:2
L Garby J S Garrow B J?rgensen O Lammert K Madsen P S?rensen J Webster 《European journal of clinical nutrition》1988,42(4):301-305
The relationship between energy expenditure and body composition, in terms of fat and fat-free masses, has previously been described by a variety of predictive regression equations with parameters devoid of physiological content. We present here results obtained by calculating the specific energy expenditure, ie, the energy expenditure per unit of mass, of fat and fat-free tissue on the basis of measurements of the total energy expenditure (EE), the masses of fat (FM), and fat-free (FFM) tissue using the following simple model: EE = k1.FM + k2.FFM where k1 and k2 are the specific energy expenditures of fat and fat-free tissue, respectively. The results of observations on 104 women at rest yielded values for k1 and k2 of 0.31 and 1.35 watts/kg of fat and fat-free mass, respectively, with standard errors of estimate of 0.074 and 0.052 watts/kg, respectively. Analysis of several series of measurements, from other sources and on smaller samples of subjects, yielded similar values at rest but with larger standard errors of estimate. Data from subjects performing varying amounts of work in 24-h measurements showed, as expected, larger values for both tissues. The results explain to a very large extent the well-established relation between resting metabolic rate and body weight, ie, a linear relation with a non-zero intercept. The results also offer a clear-cut explanation for the well known difference in energy expenditure between men and women with the same body weight. 相似文献
6.
Fixation of displaced femoral neck fractures: A comparison between sliding screw plate and four cancellous bone screws 总被引:1,自引:0,他引:1
Frank Madsen Frank Linde Erik Andersen Hanne Birke Inge Hvass Torben D. Poulsen 《Acta orthopaedica》1987,58(3):212-216
In a prospective, randomized trial, 104 consecutive patients with displaced femoral neck fractures were allocated either to fixation with a sliding screw plate or 4 ASIF cancellous bone screws. The patients were reexamined at fixed intervals to determine the time of union. The 2-year-cumulated rate of union was 64 per cent in the plate group and 84 per cent in the screw group. 相似文献
7.
8.
J. Duteil FA Rambert AM Pointeau P. Mangiameli and E. Assous 《Fundamental & clinical pharmacology》1991,5(8):695-708
The potential antidepressant effect of flerobuterol (dl-(fluoro-2 phenyl)-1 t-butylamino-2 ethanol), a new drug related to beta-adrenoceptor agonists, was evaluated and compared with imipramine and salbutamol using classical psychopharmacological tests in mice. Like imipramine and salbutamol, flerobuterol (0.5-32 mg kg-1, ip) fully prevented apomorphine (16 mg kg-1, sc)- and partly reversed reserpine- and oxotremorine-induced hypothermia. At higher doses (16-32 mg kg-1), flerobuterol enhanced the toxic effects of yohimbine. Unlike imipramine, flerobuterol and salbutamol did not reduce immobility duration in the behavioural despair test. Salbutamol and flerobuterol decreased locomotor activity. Flerobuterol did not induce mydriasis, did not prevent oxotremorine-induced tremors or salivary and lacrimal gland secretion and did not reduce reserpine-induced palpebral ptosis. Propranolol (8 mg kg-1, ip) but not alpha-methyl-paratyrosine (75 mg kg-1, ip) prevented the flerobuterol-induced antagonism of apomorphine-induced hypothermia. Our results suggest that flerobuterol demonstrates potential antidepressant activity, which could be related to beta-adrenoceptor activation in mice. 相似文献
9.
ME BURGE AM JOSHUA CM McNEIL R HUI MJ BOYER R ABRAHAM 《Asia-Pacific Journal of Clinical Oncology》2005,1(1):47-52
Background: Pemetrexed and cisplatin have recently been shown to significantly improve survival compared with cisplatin alone. However, there are only limited data reflecting teaching hospital experience outside a clinical trial. Pemetrexed has only been available in Australia on a restricted basis since 2002. We reviewed our experience of patients treated on the Australian ‘Special Access Scheme’ at three major thoracic oncology units. Methods: Charts were reviewed for all patients enrolled on the scheme. Data was extracted on age, World Health Organization (WHO) performance status, histology, prior therapy, time from diagnosis to starting pemetrexed, chemotherapy (pemetrexed alone or with a platinum), cycle number, response rate, actuarial progression‐free and overall survival. Doses were cisplatin 75 mg/m2 or carboplatin AUC = 5 and pemetrexed 500 mg/m2 every 21 days. Results: 52 patients (32 male and 20 female) were reviewed. Median age was 58 years and 88% were WHO 0–1. Histology included 54% epithelial, 17% biphasic (epithelial and sarcomatoid) and 21% undefined. The median time from diagnosis to administration of pemetrexed was 145 days. Sixty‐five percent had minimal surgical intervention with video assisted thoracoscopy, pleurodesis and biopsy, while 19% had received prior palliative radiation. Seventy‐one percent were chemotherapy naïve, the remaining 29% having received previous platinum and/or gemcitabine regimens. Twenty‐three percent had pemetrexed alone, 35% in combination with carboplatin and 42% with cisplatin. The median number of cycles was 4 (range 1–13). The response rate was 33%. No toxicity was observed in 20% grade 3–4 toxicity in 10% (majority nausea/vomiting). The median progression‐free and overall survival times from starting pemetrexed were 184 days and 298 days, respectively. Conclusions: Pemetrexed‐based regimens are safe and effective in a community setting in malignant mesothelioma. 相似文献
10.
F. Madsen 《Clinical and experimental allergy》2006,36(6):850-851